PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cabotegravir

PharmaShots Interview: ViiV Healthcare's Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020

PharmaShots Interview: ViiV Healthcare's Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Present...

December 28, 2020

ViiV Healthcare’s Apretude (cabotegravir) Receives US FDA’s Approval for the Prevention of HIV

ViiV Healthcare’s Apretude (cabotegravir) Receives US FDA’s Approval for the Prevention of HIV

December 21, 2021

PharmaShots Interview: ViiV Healthcare

PharmaShots Interview: ViiV Healthcare's Dr. Kimberly Smith Shares Insight on the Data Presented at CROI 2021

April 19, 2021

PharmaShots Interview: ViiV Healthcare

PharmaShots Interview: ViiV Healthcare's Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Present...

December 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us